Atorvastatin Decreases Bone Loss, Inflammation and Oxidative Stress in Experimental Periodontitis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  de Araújo Jr , Raimundo Fernandes ^a   Souza, Tatiana Oliveira ^a   de Moura, Lígia Moreno ^a   Torres, Kerginaldo Paulo ^a   de Souza, Lélia Batista ^a   Alves, Maria do Socorro Costa Feitosa ^a   Rocha, Hugo Oliveira ^a   de Araújo, Aurigena Antunes ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; GLUTATHIONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MALONALDEHYDE; MYELOPEROXIDASE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; OSTEOLYSIS; OXIDATIVE STRESS; PERIODONTITIS; PROTEIN EXPRESSION; RAT;

ALVEOLAR BONE LOSS; ANIMALS; HEPTANOIC ACIDS; INFLAMMATION; MALE; OXIDATIVE STRESS; PERIODONTITIS; PYRROLES; RATS; RATS, WISTAR;

EID: 84885395127     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075322     Document Type: Article

References (30)

1. Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A, (2000) Non-lipid-related effects of statins. Annals of Medicine 32: 164-176.
2. Ascer E, Bertolami MC, Venturinelli ML, Buccheri V, Souza J, et al. (2004) Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis 177: 161-166.
3. Chang B, Yang J, Li H, Lu S, Chen L, et al. (2011) Effects of atorvastatin on bone metabolism and bone mineral density in Wistar rats. Pharmazie 66: 535-537.
4. Deng P, Zhao SP, Wu J, Hong SC, Wu ZH, et al. (2005) [Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes in patients with acute myocardial infarction and modulates the early inflammatory response]. Zhonghua Xin Xue Guan Bing Za Zhi 33: 1018-1022.
5. Hernandez C, Francisco G, Ciudin A, Chacon P, Montoro B, et al. (2011) Effect of atorvastatin on lipoprotein (a) and interleukin-10: a randomized placebo-controlled trial. Diabetes Metab 37: 124-130.
6. Cui JJ, Wang D, Gao F, Li YR, (2012) Effects of atorvastatin on pathological changes in brain tissue and plasma MMP-9 in rats with intracerebral hemorrhage. Cell Biochem Biophys 62: 87-90.
7. Shirakabe A, Asai K, Hata N, Yokoyama S, Shinada T, et al. (2012) Immediate administration of atorvastatin decreased the serum MMP-2 level and improved the prognosis for acute heart failure. J Cardiol 59: 374-382.
8. Kim JY, Lee EY, Lee EB, Lee YJ, Yoo HJ, et al. (2012) Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis. Arthritis Res Ther 14: R187.
9. Otenio CC, Fonseca I, Martins MF, Ribeiro LC, Assis NM, et al. (2012) Expression of IL-1, IL-6, TNF-alpha, and iNOS in pregnant women with periodontal disease. Genet Mol Res 11.
10. Deo V, Bhongade ML, (2010) Pathogenesis of periodontitis: role of cytokines in host response. Dent Today 29: 60-62, 64-66; quiz 68-69.
11. Dalcico R, de Menezes AM, Deocleciano OB, Oria RB, Vale ML, et al. (2012) Protective Mechanisms of Simvastatin in Experimental Periodontal Disease. J Periodontol.
12. Carvalho Rde S, de Souza CM, Neves JC, Holanda-Pinto SA, Pinto LM, et al. (2013) Vitamin E does not prevent bone loss and induced anxiety in rats with ligature-induced periodontitis. Arch Oral Biol 58: 50-58.
13. Leitao RF, Ribeiro RA, Chaves HV, Rocha FA, Lima V, et al. (2005) Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats. J Periodontol 76: 956-963.
14. Souza MH, Troncon LE, Cunha FQ, Oliveira RB, (2003) Decreased gastric tone and delayed gastric emptying precede neutrophil infiltration and mucosal lesion formation in indomethacin-induced gastric damage in rats. Brazilian Journal of Medical and Biological Research 36: 1383-1390.
15. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ, (1995) Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 115: 1265-1275.
16. Kendall C, Ionescu-Matiu I, Dreesman GR, (1983) Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA). J Immunol Methods 56: 329-339.
17. Williams RC, (1990) Periodontal disease. N Engl J Med 322: 373-382.
18. Ford PJ, Gamonal J, Seymour GJ, (2010) Immunological differences and similarities between chronic periodontitis and aggressive periodontitis. Periodontol 2000 53: 111-123.
19. Wahl SM, Costa GL, Mizel DE, Allen JB, Skaleric U, et al. (1993) Role of transforming growth factor beta in the pathophysiology of chronic inflammation. J Periodontol 64: 450-455.
20. Medeiros CA, Leitao RF, Macedo RN, Barboza DR, Gomes AS, et al. (2011) Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis. Cancer Chemother Pharmacol 67: 1085-1100.
21. Barsante MM, Roffe E, Yokoro CM, Tafuri WL, Souza DG, et al. (2005) Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis. European Journal of Pharmacology 516: 282-289.
22. Pozo P, Valenzuela MA, Melej C, Zaldivar M, Puente J, et al. (2005) Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients. Journal of Periodontal Research 40: 199-207.
23. Corotti MV, Zambuzzi WF, Paiva KB, Menezes R, Pinto LC, et al. (2009) Immunolocalization of matrix metalloproteinases-2 and-9 during apical periodontitis development. Archives of Oral Biology 54: 764-771.
24. Hofbauer LC, Heufelder AE, (2001) Role of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin in bone cell biology. Journal of Molecular Medicine-Jmm 79: 243-253.
25. Hsu HL, Lacey DL, Dunstan CR, Solovyev I, Colombero A, et al. (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proceedings of the National Academy of Sciences of the United States of America 96: 3540-3545.
26. Caetano-Lopes J, Canhao H, Fonseca JE, (2007) Osteoblasts and bone formation. Acta Reumatologica Portuguesa 32: 103-110.
27. Kirkwood KL, Cirelli JA, Rogers JE, Giannobile WV, (2007) Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 43: 294-315.
28. Yen CA, Damoulis PD, Stark PC, Hibberd PL, Singh M, et al. (2008) The effect of a selective cyclooxygenase-2 inhibitor (celecoxib) on chronic periodontitis. J Periodontol 79: 104-113.
29. Araujo AA, Lopes de Souza G, Souza TO, de Castro Brito GA, Saboia Aragao K, et al. (2013) Olmesartan decreases IL-1beta and TNF-alpha levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. Naunyn Schmiedebergs Arch Pharmacol.
30. Araújo Júnior RFd, Souza TO, Medeiros CAXd, Souza LBd, Freitas MdL, et al. (2013) Carvedilol Decrease IL-1β and TNF-α, Inhibits MMP-2, MMP-9, COX-2, and RANKL Expression, and Up-Regulates OPG in a Rat Model of Periodontitis. PLoS One 8: e66391.